1
|
Comparative evaluation of lesion detectability for 6 PET imaging platforms using a highly reproducible whole-body phantom with (22)Na lesions and localization ROC analysis.
|
J Nucl Med
|
2002
|
1.99
|
2
|
EANM/SNMMI guideline for 18F-FDG use in inflammation and infection.
|
J Nucl Med
|
2013
|
1.37
|
3
|
Estimating myocardial perfusion from dynamic contrast-enhanced CMR with a model-independent deconvolution method.
|
J Cardiovasc Magn Reson
|
2008
|
1.01
|
4
|
Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.
|
Clin Nucl Med
|
2012
|
0.92
|
5
|
Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
|
J Nucl Med
|
2009
|
0.90
|
6
|
(18)F-FDG PET in the evaluation of acuity of deep vein thrombosis.
|
Clin Nucl Med
|
2012
|
0.88
|
7
|
Amyloid deposition and cognition in older adults: the effects of premorbid intellect.
|
Arch Clin Neuropsychol
|
2013
|
0.81
|
8
|
Nuclear medicine practitioner competencies.
|
J Nucl Med Technol
|
2007
|
0.76
|
9
|
Comparison of Static and Dynamic Cardiac Perfusion Thallium-201 SPECT.
|
IEEE Trans Nucl Sci
|
2001
|
0.75
|
10
|
Position paper on the development of a middle level provider in nuclear medicine: the nuclear medicine practitioner.
|
J Nucl Med Technol
|
2006
|
0.75
|
11
|
Measurements of activation products associated with Havar foils from a GE PETtrace medical cyclotron using high resolution gamma spectroscopy.
|
Health Phys
|
2009
|
0.75
|
12
|
Easy method of patient positioning for convergent-beam cardiac SPECT.
|
J Nucl Med Technol
|
2007
|
0.75
|